Aemetis (NASDAQ:AMTX) Stock Rating Upgraded by StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by analysts at StockNews.com to a “sell” rating in a research report issued on Monday.

Separately, HC Wainwright reissued a “buy” rating and set a $28.00 price target on shares of Aemetis in a research report on Monday, December 23rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Price Performance

AMTX opened at $2.25 on Monday. The stock has a market capitalization of $111.92 million, a price-to-earnings ratio of -1.00 and a beta of 1.47. Aemetis has a 12 month low of $2.04 and a 12 month high of $7.03. The business has a 50-day moving average of $3.03 and a two-hundred day moving average of $2.91.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same period in the prior year, the business earned ($0.59) EPS. Equities research analysts anticipate that Aemetis will post -2.07 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Rhumbline Advisers grew its stake in shares of Aemetis by 2,837.1% in the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock valued at $157,000 after buying an additional 50,528 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its position in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after acquiring an additional 93,536 shares in the last quarter. FMR LLC raised its stake in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after purchasing an additional 9,137 shares during the period. State Street Corp lifted its position in shares of Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Finally, Wellington Management Group LLP purchased a new position in shares of Aemetis in the third quarter valued at $177,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.